ISCO News Alert Intl Stem Cell Corp (ISCO) 0.0950 09/20/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Intl Stem Cell Corp (ISCO) 0.0950 $ISCO

International Stem Cell Corporation to Present at Two Upcoming Investment Conferences
Marketwire - Thu Aug 28, 7:30AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, today announced that Executive Vice President Dr. Simon Craw will present a corporate overview of ISCO and its subsidiaries at two upcoming investment conferences.

International Stem Cell Corporation Provides R&D and Business Results for Second Quarter and First Half of 2014
Marketwire - Tue Aug 12, 7:32AM CDT
International Stem Cell Corporation (OTCQB: ISCO), a California-based biotechnology company developing novel stem cell based therapies and biomedical products today provided a business update and announced financial results for the three and six months ended June 30, 2014.

International Stem Cell Corporation to Host Second Quarter 2014 Business Update and Financial Results Conference Call at 11:00 am ET on Tuesday, August 12, 2014
Marketwire - Thu Aug 07, 7:32AM CDT
International Stem Cell Corporation (OTCQB: ISCO) a California-based biotechnology company developing novel stem cell based therapies and biomedical products announced today that it will host a conference call on Tuesday, August 12, 2014 to provide a business update and discuss its financial results for the three and six months ended June 30, 2014.

International Stem Cell Corporation Launches Stroke Program With Tulane University
Marketwire - Tue Aug 05, 7:33AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company" , a California-based biotechnology company developing novel stem cell based therapies, announced today that it has launched a new Stroke Program. Together with Tulane University, ISCO will study the impact of human parthenogenetic neural stem cells (hpNSC) transplantation in a pre-clinical rodent model of ischemic stroke as a first step toward the clinical development of a potential stroke treatment. The proof-of-concept study will be done in the laboratory of Dr. Jean-Pyo Lee, a well-known expert in the field of regenerative medicine.

International Stem Cell Corporation Secures Approval for Core Technology Patents in European Union
Marketwire - Tue Jul 22, 7:32AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company" , a California-based biotechnology company developing novel stem cell based therapies and biomedical products, received formal opinion from the Advocate General for the European Union Court of Justice (CJEU) in favor of the Company's pending core technology patents.

Lifeline Cell Technology Expands Asian Distribution Network
Marketwire - Wed Jul 16, 7:30AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company" , a California-based biotechnology company focused on therapeutic and research products, today announced that its subsidiary, Lifeline Cell Technology, has expanded its sales network by adding a number of new distributors in Asia and Oceania.

International Stem Cell Corporation Signs Agreement Including Certain Terms for a Definitive License Agreement With Rohto Pharmaceutical Co., Ltd. of Japan
Marketwire - Tue Jul 08, 7:30AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com, ISCO or the Company), a California-based biotechnology company developing novel stem cell-based therapies, announced today that it has entered into a research agreement with Rohto Pharmaceutical Co., Ltd. ("Rohto" , a global Japanese pharmaceutical company that develops new technology for the medical and cosmetics markets with approximately $1.3 billion in consolidated annual sales. Under this agreement, Rohto will evaluate stem cell-derived human cells owned and provided by ISCO in a number of pre-clinical animal models. If the research is successful and the parties agree on remaining terms, it is anticipated that a definitive license agreement will be signed at the end of the twelve-month period of this research agreement. Certain key terms of such a license agreement, including the target disease areas and intellectual property rights, have been established in the research agreement.

International Stem Cell Corporation Completes Important Study in Parkinson's Disease Program
Marketwire - Thu Jun 19, 7:30AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company" , a California-based biotechnology company developing novel stem cell based therapies, announced today the completion of the acute toxicity study of the Company's proposed clinical product to treat Parkinson's disease. The recently completed IND-enabling study transplanting rodents with human neural stem cells, derived from ISCO's proprietary parthenogenetic stem cell platform, showed that the cells are well tolerated even at high doses up to the equivalent of 2.2 billion cells in humans. The program continues to progress according to the plan outlined with the FDA at the pre-IND meeting as reported in February 2014. The Company intends to provide a further update early next quarter.

International Stem Cell Corporation to Present at BIO 2014
Marketwire - Tue Jun 17, 2:24PM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, today announced that Executive Vice President Dr. Simon Craw, will present an overview of ISCO and its subsidiaries at the BIO 2014 conference on Tuesday, June 24th at 4:15 pm PDT. The conference is being held at the San Diego Convention Center.

Lifeline Skin Care Expands Into Latin America's Second Largest Market
Marketwire - Tue Apr 01, 7:30AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com), a California-based biotechnology company developing novel stem cell-based therapies and biomedical products, announced today that Lifeline Skin Care, its operating subsidiary, has signed a distribution agreement with Grupo Venta Internacional, S.A de C. V., Mexico's largest distributor of aesthetic and reconstructive products. Effective immediately, Grupo Venta Internacional will offer Lifeline's breakthrough stem cell skin care products to health care professionals throughout Mexico, the second largest market for aesthetic skin care in Central and South America.

International Stem Cell Corporation Announces 2013 Fourth Quarter and Year-End Results
Marketwire - Tue Mar 18, 7:31AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company" , a California-based biotechnology company developing novel stem cell-based therapies and biomedical products, today provided a business update and announced fourth quarter and year-end financial results for the year ended December 31, 2013.

International Stem Cell Corporation to Host Full-Year 2013 Business Update and Financial Results Conference Call Wednesday, March 19, 2014
Marketwire - Thu Mar 13, 7:31AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com), a California-based biotechnology company developing novel stem cell-based therapies and biomedical products announced today that management will host a conference call on Wednesday, March 19, 2014 to provide a business update and discuss its financial results for the year ended December 31, 2013.

Odemwingie Pleased With Stoke Debut
All Africa Global Media - Tue Feb 04, 4:56AM CST
Out of favour Super Eagles forward, Osaze Peter Odemwingie has spoken of his delight following his Barclays English Premier League debut for Stoke City last weekend. Odemwingie completed an 18-month move to the Britannia Stadium on January 28 and was immediately thrown into the deep end by the Stoke Manager, Mark Hughes, against Manchester United on Saturday.

International Stem Cell Corporation Advances Parkinson's Disease Program Towards IND Stage
Marketwire - Mon Sep 09, 7:30AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com), a California-based biotechnology company developing novel stem cell-based therapies, announced today further progress in its Parkinson's disease program with a recently held key opinion leader meeting facilitated by the study's principal investigator, Dr. Mark Stacy of Duke Medicine.

International Stem Cell Corporation to Present at Rodman & Renshaw 15th Annual Global Investment Conference September 8th to 10th
Marketwire - Wed Aug 28, 7:30AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com), a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today that it will participate in Rodman & Renshaw's 15th Annual Global Investment Conference sponsored by H.C. Wainwright & Co., LLC. The conference is being held September 8-10, 2013, at the Millennium Broadway Hotel in New York City.

International Stem Cell Corporation Enters Into Clinical Research Agreement for Parkinson's Disease Program
Marketwire - Wed Aug 21, 7:30AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) a California-based biotechnology company developing novel stem cell-based therapies, announced today that it has entered into a master clinical research agreement with Duke University to conduct clinical trials research in Parkinson's disease using ISCO's innovative neural stem cell product.

International Stem Cell Corporation Announces Second Quarter 2013 Financial Results
Marketwire - Thu Aug 08, 7:30AM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company" , a California-based biotechnology company developing novel stem cell based therapies and biomedical products, today announced financial results for the three and six months ended June 30, 2013.

Crystal Research Associates, LLC Issues Executive Informational Overview (EIO) on International Stem Cell Corporation
Marketwire - Tue Aug 06, 7:30AM CDT
Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO) on International Stem Cell Corporation (OTCQB: ISCO). The full 72-page report is available on Crystal Research Associates' website at www.crystalra.com.

International Stem Cell Corporation to Host Second Quarter 2013 Financial Results Conference Call at 11:00 a.m. ET on Friday, August 9, 2013
Marketwire - Thu Aug 01, 4:00PM CDT
International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) a California-based biotechnology company developing novel stem cell based therapies and biomedical products announced today that it will host a conference call on Friday, August 9, 2013 to discuss its financial results for the three and six months ended June 30, 2013.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Teachstone’s Bronze Award Puts Classroom Quality in Focus

Updated Category News Views 36

Small Classroom Moments Finally Get Their Due A child’s hesitant question can disappear in the noise of a busy classroom, which is precisely why Teachstone’s latest recognition deserves more than the usual polite golf clap. The Charlottesville-based Certified B Corporation received a Bronze Anthem Award for its “From Measurement to Momentum” initiative, in the...

Continue Reading
Cloud Security’s $26.8 Billion Test Is All About Execution

Updated Category News Views 65

A cloud dashboard that spits out ten thousand alerts is not protection; it is an expensive way to make a security team miserable. That frustration sits right in the middle of Frost & Sullivan’s projection that global cloud security revenue will climb from $8.4 billion in 2025 to $26.8 billion by 2031, a 21.4% compound annual growth rate. The number is hefty, no...

Continue Reading
Why Dent Repair Estimates Need More Than a Simple Ruler

Updated Category News Views 118

A dent can look harmless in a parking-lot glare and still turn into a stubborn repair job once somebody examines the metal properly. That is the useful, unglamorous point Jason Phelps of Magic Dent makes in a HelloNation article: visible diameter is not a verdict. Anybody shopping for vehicle repairs, managing fleet costs, or watching the collision-service ecosystem ought...

Continue Reading
San Bernardino Teamsters Back Their Historic Contract

Updated Category News Views 86

A 90% vote does not whisper; it rattles the filing cabinets. More than 12,000 San Bernardino County members of Teamsters Local 1932 have ratified a new labor agreement with over 90% approval, according to the union’s November 20 announcement. In a public-sector negotiation, that kind of margin matters because it tells management the workforce is not merely accepting a...

Continue Reading
GIGABYTE Pitches Local AI Agents to Enterprise Buyers

Updated Category News Views 72

Enterprise AI has reached the awkward stage where a slick chatbot demo no longer cuts it. GIGABYTE used its November 13 AI Partner Summit at the Pacific Palms Resort to make a more grounded pitch: companies need hardware and software setups that can put AI agents to work without casually tossing proprietary information into somebody else’s cloud. That is a sensible...

Continue Reading
Label-Free Detection Has a Solid, Narrow Growth Lane

Updated Category News Views 133

Biologics labs are turning into a far better hunting ground for analytical equipment than the old, broad-brush research story suggests. Label-free detection is not a giant market, and nobody should dress it up as one. But the projected move from $0.58 billion in 2026 to $0.85 billion by 2031 points to a useful 8.1% annual growth lane, driven by work researchers genuinely...

Continue Reading
Travel Disruptions Reveal the Value of Human Support

Updated Category News Views 95

Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...

Continue Reading
Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 121

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
Neurelis Founder Earns EY's 2026 Top Entrepreneur Honor

Updated Category News Views 95

Some business awards are wallpaper; this one carries real clinical weight. EY US named Craig Chambliss, CEO and co-founder of Neurelis, its Entrepreneur Of The Year 2026 National Overall Award winner. In a sector where plenty of companies talk grandly about changing lives and then vanish into the regulatory fog, the underlying story matters more than the trophy. Neurelis...

Continue Reading
Alabama Power's 2027 Cut Puts Data Centers to Work

Updated Category News Views 87

Data centers rarely arrive bearing a gift for ordinary power customers. Yet Alabama Power says its coming load growth will help cut customer rates by $160 million in 2027, beginning with January bills. In a utility world stuffed with requests for more money, that is a sharp change of pace. The company filed the reduction with the Alabama Public Service Commission on Nov....

Continue Reading

Top 5 Most Recently Viewed Articles

Arcline Investment Management Sells Resolution Medical to Resonetics

Updated Category News Views 213

Arcline Investment Management Sells Resolution Medical Arcline Investment Management, a dynamic private equity firm, has made a notable move in the medical technology landscape. The firm is set to sell its portfolio company, Resolution Medical, to Resonetics. This strategic decision highlights Arcline's ongoing commitment to advancing innovative solutions within the...

Continue Reading
Cheetah Mobile Surges with Impressive Q2 Financial Results

Updated Category News Views 223

Cheetah Mobile Reports Strong Growth in Q2 2025 Cheetah Mobile Inc. (NYSE: CMCM), a prominent IT company, has recently reported its financial results for the second quarter of 2025. The results indicate a remarkable increase in total revenue and profitability, showcasing the company’s ongoing strategic transformation. Management Insights on Performance Mr. Sheng Fu,...

Continue Reading
OwlTing Group Launches OwlPay Harbor for Enhanced Payment Solutions

Updated Category News Views 287

OwlTing Group Transforms Payments with AI-Powered OwlPay Harbor OwlTing Group, a pioneering blockchain fintech firm, has announced a significant evolution of its payment platform, OwlPay Harbor. This innovative service integrates artificial intelligence to enhance the experience for developers and users alike, making financial transactions faster and more secure than ever...

Continue Reading
Colt DCS Taps Nguyen for CEO Amid Growth Surge

Updated Category News Views 24

Nguyen Takes Helm at Colt DCS Well, here's a move that'll definitely shake the data center landscape a bit: Quy Nguyen's stepping up as the Chief Executive Officer at Colt Data Centre Services. From temporary to permanent, that decision speaks volumes about the trust in his leadership acumen during these transformative times. Colt's apparently betting the farm on Nguyen...

Continue Reading
NWR Storage Containers Expands with New Facility Opening

Updated Category News Views 143

NWR Storage Containers Expands with New Facility Opening NWR Storage Containers, a prominent provider of storage container rentals, is excited to announce its relocation to a larger facility. This event marks a significant step forward in their journey of growth and commitment to serving customers effectively. Relocation to a New Facility The newly established operations...

Continue Reading